Thalassemia secondary prevention

Jump to navigation Jump to search

Thalassemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thalassemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thalassemia secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thalassemia secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thalassemia secondary prevention

CDC on Thalassemia secondary prevention

Thalassemia secondary prevention in the news

Blogs on Thalassemia secondary prevention

Directions to Hospitals Treating Thalassemia

Risk calculators and risk factors for Thalassemia secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shyam Patel [2]

Overview

There is some role for genetic counseling and education as a means of secondary prevention of thalassemia.

Secondary Prevention

Secondary prevention for thalassemia focuses on preventing the birth of infants who could be at risk for thalassemia. Secondary prevention involves genetic counseling of patients who are known carriers of alpha-globin or beta-globin chain mutations. Education programs have been instituted in a variety of countries to address secondary prevention.[1]

References

  1. Cao A, Kan YW (2013). "The prevention of thalassemia". Cold Spring Harb Perspect Med. 3 (2): a011775. doi:10.1101/cshperspect.a011775. PMC 3552345. PMID 23378598.

Template:WH Template:WS